2022
DOI: 10.47750/pnr.2022.13.s06.454
|View full text |Cite
|
Sign up to set email alerts
|

Evaluating the Hatch-Waxman Amendment’s Influence on Fda's Generic Medication Approval Process

Abstract: Generics are drugs marketed by their chemical names, not brand names or chemical compositions. Generic drugs are less expensive. The United States Food and Drug Administration (USFDA) allows generic drugs when patents expire or owners renounce their rights. Competition lowers drug prices once generics are accessible. The Food and Drug Administration monitors the drug business. The Senate confirms the Food and Drug Administration Commissioner's nomination. Food and medications are controlled less than lasers, c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 12 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?